The Blau Syndrome Market is navigating a transformative period as advancements in genetic research and orphan drug designations accelerate the development of targeted therapies. Characterized by a triad of granulomatous dermatitis, arthritis, and uveitis, this rare autoinflammatory disorder requires specialized, lifelong management to prevent systemic complications. https://livepositively.com/unlocking-value-pricing-regulatory-landscape-and-future-forecast-for-the-ocular-bromfenac-market-2025-2032/